Interleukin-10 (IL-10) is a pleiotropic cytokine that controls inflammatory
processes by suppressing the production of proinflammatory cytokines that
are known to be transcriptionally regulated by nuclear factor-kappaB (NF-ka
ppaB). Although still controversial, IL-10 has been shown to inhibit NF-kap
paB activation through a process that involves proteolytic degradation of i
nhibitory subunit I kappaB-alpha. What is not known, however, is the mechan
ism by which IL-10 exerts its effect on I kappaB-alpha degradation. The pre
sent study investigates the possible role of reactive oxygen species (ROS)
and their inhibition by IL-10 in NF-kappaB activation and I kappaB-alpha de
gradation in macrophages. Treatment of the cells with lipopolysaccharide (L
PS) caused activation of NF-kappaB and rapid proteolysis of I kappaB-alpha
as determined by the electrophoretic mobility shift assay, gene transfectio
n, and Western blot. IL-10 pretreatment inhibited both NF-kappaB activation
and I kappaB-alpha degradation. Both of these processes were also inhibite
d by ROS scavengers, catalase (H2O2 scavenger), and sodium formate (. OH sc
avenger) but were minimally affected by superoxide dismutase (O-2(-) scaven
ger). These results suggests that . OH radicals, formed by an H2O2-dependen
t, metal-catalyzed Fenton reaction, play a major role in this process. Elec
tron spin resonance studies confirmed the formation of . OH radicals in LPS
-treated cells. Addition of IL-10 inhibited both I kappaB-alpha degradation
and generation of . OH radicals in response to LPS stimulation. These resu
lts demonstrate, for the first time, direct evidence for the role of IL-10
in ROS-dependent NF-kappaB activation.